ARCHIVES

FDA Working On New Ground Rules For “Adaptive” Clinical Trial Designs.

This article is from The Cancer Letter archive.

Vol. 32 No. 27 | July 14, 2006

Download PDF Visit The Full Archive

Related Articles

Six Panels To Help NCI Identify Progress; NCINews Roundup

January 8, 1993

DCT Board Approves $17 Million In Recompetition; Asks Some Be Switched To Cooperative Agreements

November 23, 1979

NTP Board Okays concept for New In Vitro study Using Oncogenes

May 10, 1985

Group Chairs Respond to Center Directors’ White Paper

April 1, 2011

Preliminary Report Tends To Support Pill’s Association With Liver Tumors

November 19, 1976

Cancer Center Planning Grants Recompetition Approved By Advisors

June 10, 1994